Federation Des Caisses Desjardins Du Quebec Pds Biotechnology Corp Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 9,000 shares of PDSB stock, worth $14,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,000
Previous 9,000
-0.0%
Holding current value
$14,760
Previous $26,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$798,6250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$680,7850.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$564,8060.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$384,1020.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $46.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...